Skip to content

electroCore, Inc. ECOR Other accrued liabilities

Other accrued liabilities at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Avanos Medical logo
Avanos MedicalAVNS
LivaNova logo
LivaNovaLIVN
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+81.6%
Enterprise value$76.31M+90.2%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Reported directly by electroCore, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s other accrued liabilities?
electroCore, Inc. (ECOR) reported other accrued liabilities of $216K in Q1 2026.
How has electroCore, Inc.'s other accrued liabilities changed year-over-year?
electroCore, Inc.'s other accrued liabilities decreased by 32.9% year-over-year, from $322K to $216K.
What is the long-term trend for electroCore, Inc.'s other accrued liabilities?
Over 4 years (2021 to 2025), electroCore, Inc.'s other accrued liabilities has grown at a 1.2% compound annual growth rate (CAGR), from $347K to $364K.